VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EHA 2020 | New and emerging drug targets for older AML patients

Nigel Russell, MD, of Guy’s Hospital NHS Trust, London, UK, explores new and emerging drug targets for acute myeloid leukemia (AML). Specifically discussed by Dr Russell is the use of venetoclax with azacitidine, updates in the VIALE-A study (NCT02993523) and magrolimab, an anti-CD47 antibody. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter